SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-323914
Filing Date
2020-12-22
Accepted
2020-12-22 08:16:00
Documents
12
Period of Report
2020-12-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d19234d8k.htm   iXBRL 8-K 56915
  Complete submission text file 0001193125-20-323914.txt   181591

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nvus-20201218.xsd EX-101.SCH 3085
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvus-20201218_lab.xml EX-101.LAB 18139
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvus-20201218_pre.xml EX-101.PRE 11418
5 EXTRACTED XBRL INSTANCE DOCUMENT d19234d8k_htm.xml XML 3398
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 201406096
SIC: 2834 Pharmaceutical Preparations